Total Funding
3
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
876056
AktiVaxTM develops novel reconstitution and safety syringes for vaccines and biologics.
- Amir Genosar: President and CEO
About the Company
AktiVaxTM is creating a paradigm shift in vaccine delivery that will solve vaccine partners’ problems, costs, and complexities by providing an alternative to the traditional syringe and vial system. AktiVax’s solution involves a three-pillared approach: expertise in cost-effective, dry vaccine formulation; differentiated delivery devices; and
efficient manufacturing for rapid market distribution. Our proposition has already attracted a number of vaccine partners representing a significant portion of the $30 billion vaccine industry. We believe that our solution will create a new standard of care in the vaccine market.
